##  [LXE408](/node/36411 "LXE408") 

  



LXE408

[In-market Brands and Global Health](/taxonomy/term/11046)

[Phase 2](/taxonomy/term/2881)

[≥ 2029](/taxonomy/term/11576)

[Proteasome inhibitor](/taxonomy/term/3081)

 

Visceral leishmaniosis

[Lead Indication](/taxonomy/term/2811)



- [Print](/node/36411/printable/print)
- [PDF](/node/36411/printable/pdf)